These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 422703)

  • 21. [Aldosterone and progesterone content and blood renin activity in women with idiopathic edema syndrome in various phases of menstrual cycle].
    Atamanova TM; Egart FM; Zelenetskaia VS
    Probl Endokrinol (Mosk); 1979; 25(6):32-6. PubMed ID: 574961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of Parkinson's syndrome with L-dopa and L-carbidopa (author's transl)].
    Hanzal F
    MMW Munch Med Wochenschr; 1976 May; 118(20):653-6. PubMed ID: 818540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of patients with vascular parkinsonism with the preparations nakom and madopar].
    Kamenetskiĭ VK
    Klin Med (Mosk); 1984 Apr; 62(4):112-6. PubMed ID: 6737958
    [No Abstract]   [Full Text] [Related]  

  • 24. [Controlled study on the possibilities of L-dopa in the residual extrapyramidal syndrome caused by neuroleptics].
    Gutiérrez M; Alpert M; Guimón J; Friedhoff AJ; Veramendi V
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1979; 7(3):181-8. PubMed ID: 382762
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy of rigidity and hypokinesis in old age using Sinemet].
    Drobný M; Adamkov J; Svaleková A; Fundárek J
    Cesk Neurol Neurochir; 1979 May; 42(3):195-204. PubMed ID: 455524
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies of the mechanism of sodium retention in idiopathic edema.
    Ferris TF; Chonko AM; Williams JS; Reineck HJ; Stein JH
    Trans Assoc Am Physicians; 1973; 86():310-9. PubMed ID: 4788801
    [No Abstract]   [Full Text] [Related]  

  • 27. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
    Meco G; Casacchia M; Zamponi A; Agnoli A
    Acta Neurol (Napoli); 1976; 31(4):479-48. PubMed ID: 1037427
    [No Abstract]   [Full Text] [Related]  

  • 28. Receptor-cell sensitivity modification (RSM) as a model for pathogenesis and treatment of tardive dyskinesia.
    Friedhoff AJ; Rosengarten H; Bonnet K
    Psychopharmacol Bull; 1978 Oct; 14(4):77-9. PubMed ID: 704769
    [No Abstract]   [Full Text] [Related]  

  • 29. [Renin and aldosterone regulation in idiopathic edemas].
    Werning C; Siegenthaler W
    Bratisl Lek Listy; 1972 Apr; 57(4):385-92. PubMed ID: 5018682
    [No Abstract]   [Full Text] [Related]  

  • 30. [Decarboxylase inhibitors combined with L-dopa in the treatment of Parkinson's disease].
    Rondot P
    Rev Prat; 1974 Mar; 24(15):1211-2, 1215-6, 1219. PubMed ID: 4416964
    [No Abstract]   [Full Text] [Related]  

  • 31. Dopaminergic activity in idiopathic oedema.
    Norbiato G; Bevilacqua M; Raggi U; Micossi P
    Lancet; 1977 Nov; 2(8047):1088. PubMed ID: 73002
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study].
    Hayek J
    Schweiz Med Wochenschr; 1977 Apr; 107(14):474-9. PubMed ID: 847450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine?
    Coruzzi P
    J Clin Endocrinol Metab; 1994 Feb; 78(2):455-8. PubMed ID: 8106635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of apomorphine and apomorphine-L-dopa-carbidopa on alcohol post-intoxication symptoms.
    Wadstein J; Ohlin H; Stenberg P
    Drug Alcohol Depend; 1978 Jul; 3(4):281-7. PubMed ID: 357128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced response of plasma prolactin to metoclopramide during chronic converting enzyme inhibition.
    Dupont AG; Van der Nipen P; Van Steirteghem AC; Vanhaelst L
    Horm Metab Res; 1987 May; 19(5):212-5. PubMed ID: 3034757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Idiopathic edema (IE). Relationship between renin, aldosterone, catecholamines and prolactin].
    Degli Esposti E; Cogliandro SE; Fuschini G; Rambaldi R; Flamigni C; Zucchelli P
    Minerva Nefrol; 1979; 26(4):505-8. PubMed ID: 396489
    [No Abstract]   [Full Text] [Related]  

  • 37. [Aldosterone response to metoclopramide, a dopaminergic inhibitor, in normal men; evaluation of the mechanisms (author's transl)].
    Mizuno K; Yamazaki M; Toki T; Ono Y; Hashimoto S; Yaginuma K; Nagasawa S; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):175-80. PubMed ID: 7047824
    [No Abstract]   [Full Text] [Related]  

  • 38. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
    García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
    Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison between results achieved by administering L-dopa and Sinemet in parkinsonism in the light of our records].
    Szulc-Kuberska J; Niewodniczy A; Poźniak-Patewics E; Wolczyk-Orzechowska M
    Neurol Neurochir Pol; 1975; 9(5):611-5. PubMed ID: 1186952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is aldosterone secretion under dopaminergic control?
    Campbell DJ; Mendelsohn FA; Adam WR; Funder JW
    Circ Res; 1981 Dec; 49(6):1217-27. PubMed ID: 7030512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.